Anthrax Vaccine Consent Form / Should You Roll Up Your Sleeves_WSJ Sat, 29 Mar 2003 The Administration’s determination to push its two controversial vaccine programs forward–smallpox and anthrax–even as medical experts urge caution in light of the serious health risks posed by these vaccines – raises serious questions about whose…
Tamiflu Cited in 2 Teen Deaths – Global Plan for Influenza Action – Lancet Monday, November 14, 2005 Japanese newspapers report that two teenage boys – one 14 the other 17 – died after taking one dose of the antiviral drug, Tamiflu, the drug being stockpiled in the event that…
"UK regulators did not receive findings that might have warned them of damage TGN1412 could do."
"The drugs most commonly used to soothe agitation and aggression in people with Alzheimer’s disease are no more effective than placebos for most patients, and put them at risk of serious side effects, including confusion, sleepiness and Parkinson’s disease-like symptoms, researchers are reporting
today."
Two especially timely conferences focus on MEDICINE AND THE LAW:
An editorial in today's New York Times is a follow-up to its riveting report by Ian Urbina on the recommendation by an Institute of Medicine panel to
lift 1978 federal restrictions on medical experiments on prisoners. http://www.nytimes.com/2006/08/13/us/13inmates.html?
Industry’s blockbuster sellers–the atypical antipsychotics performed WORSE than their cheaper, non-patented precursors.
CYBERONICS ANNOUNCES MECHANISM OF ACTION ADVISORY BOARD
Three essays provide an overview of the bias that has debased the integrity of medical research literature while increasing the hazards of medical practice–for patients and doctors who are kept in the dark about prescribed treatment dangers.
A front page report in The New York Times describes a psychotropic drug-induced catastrophe that has befallen patients who obeyed their
psychiatrists, and swallowed the antipsychotic drugs prescribed by psychiatrists who insisted the drugs were for the patients own good.
Our criticism of a high risk, speculative drug experiment conducted on healthy children and adolescents at Yale University’s Psychiatric Institute was validated by a federal investigation: and our criticism is now validated by the principle investigator, Dr. Thomas McGlashan.
Under the influence of pharmaceutical companies, physicians anhd drug companies engage in "disease mongering." Below is a critique of Dr. David Healy’s essay: Dr. Nassir Ghaemi who argues for the legitimacy of bipolar diagnosis.
